Certis Oncology Announces Closing of $10 Million Series C Fundraising Round

SAN DIEGO–(BUSINESS WIRE)– #CertaintySavesLives–Certis Oncology Solutions (Certis), a precision oncology and translational science company focused on combining AI-directed drug development with advanced functional testing, today announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million. The company also named John R. Tozzi…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks